CA
NZ
UK
AU
IND
US
Net income was USD 49.2 million, or USD 49.5 million as adjusted, equal to diluted EPS of USD 0.32. Operating revenues were USD 179.4 million, up 1.3% from the second quarter on higher average assets, partly offset by lower transaction fees from European ETPs …
Chairman and chief executive Darren Woods said Middle East conflict continued to disrupt trade flows and constrain supplies of crude, diesel, gasoline and other finished products, producing short markets and higher prices.
Key HighlightsSandisk (NASDAQ:SNDK) fell 13.47 percent on October 30, 2026 to close at USD 1,150.89, after reporting fiscal first quarter 2027Revenueof USD 11.03 billion, up 378 percent from a year earlier and up 23 percent sequentially.Non-GAAPEarningswere USD 49.51 per share against about USD 46.67 …
The less comfortable part of the report is Eylea, the eye drug that was once Regeneron's largest product. Original Eylea US sales fell 41 percent to USD 400 million as competition andBiosimilarsarrived over the past year, including Pavblu from Amgen (NASDAQ:AMGN), which reported USD …
Coursera completed itsAcquisitionof Udemy in May 2026, which makes year-over-year comparisons less clean because the combinedBusinessis being measured against a smaller base. Combined revenue fell 3 percent, as Enterprise grew 2 percent and Consumer fell 9 percent. The company said it now expects to …
Fabrinet builds optical communication components, automotive parts, medical devices and industrial lasers and sensors for customers, according to the company description. A contract model typically produces thin percentage margins on large volumes: revenue can climb quickly while gross margin stays near 12 percent, so …
Gross margin is the lever to watch. The second quarter non-GAAP margin of 39.3 percent compares with a guide of 40.0 to 42.0 percent, which implies improvement of roughly 70 to 270 basis points, simple arithmetic on the ends of the range. Management called …
Vertex earns most of its revenue from cystic fibrosis medicines, so growth beyond that base depends on launches. Alyftrek, its newer cystic fibrosis treatment, grew from USD 156.8 million to USD 573.6 million year over year. Casgevy, a gene-edited therapy for blood disorders, brought …
North America carried the second quarter, with US and Canada RevPAR up 5 percent, while international RevPAR slipped 0.5 percent and Europe, the Middle East and Africa fell about 5 percent as conflict in the Middle East cut travel. Marriott raised full-year worldwide RevPAR …
In fiscal 2026 Asia Pacific organic sales rose mid-single digits on Asia travel retail, with Korea, Hong Kong and Hainan growing, while rest of mainland China travel retail fell after a change in duty-free retailers at the Beijing and Shanghai airports. Mainland China overall …
Please wait processing your request...